These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 8704058

  • 1. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A, Kessler AC.
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1994 Apr; 14(6B):2743-6. PubMed ID: 7532929
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of four serological tumor markers for the detection of breast cancer.
    Clinton SR, Beason KL, Bryant S, Johnson JT, Jackson M, Wilson C, Holifield K, Vincent C, Hall M.
    Biomed Sci Instrum; 2003 Apr; 39():408-14. PubMed ID: 12724928
    [Abstract] [Full Text] [Related]

  • 6. [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum].
    Ial'chenko NA, Lagutin VD, Lavik NN, Musin II.
    Vopr Onkol; 1991 Apr; 37(9-10):921-4. PubMed ID: 1726842
    [Abstract] [Full Text] [Related]

  • 7. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
    Hasholzner U, Stieber P, Reiter W, Zimmermann A, Hofmann K, Schalhorn A.
    Anticancer Res; 1999 Mar; 19(4A):2477-80. PubMed ID: 10470177
    [Abstract] [Full Text] [Related]

  • 10. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
    Pasanen PA, Kauppinen R, Eskelinen M, Partanen K, Pikkarainen P, Alhava E.
    Anticancer Res; 1993 Mar; 13(3):763-8. PubMed ID: 8317910
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A.
    Anticancer Res; 1997 Mar; 17(4B):2903-6. PubMed ID: 9329559
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K, Chung YS, Umeyama K, Takeuchi T, Kim YS.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F, Roselli M, Amato T, Cosimelli M, Perri P, Casale V, Carlini M, Santoro E, Cavaliere R, Greiner JW.
    Cancer Res; 1992 Mar 01; 52(5):1222-7. PubMed ID: 1737383
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M, Kataja V, Hämäläinen E, Kosma VM, Penttilä I, Alhava E.
    Anticancer Res; 1997 Mar 01; 17(2B):1231-4. PubMed ID: 9137478
    [Abstract] [Full Text] [Related]

  • 19. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
    Eskelinen M, Pasanen P, Janatuinen E, Pettersson N, Linnane A, Alhava E.
    Anticancer Res; 1995 Mar 01; 15(5B):2351-6. PubMed ID: 8572651
    [Abstract] [Full Text] [Related]

  • 20. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
    Lopez JB, Balasegaram M, Timor J, Thambyrajah V.
    Malays J Pathol; 1997 Jun 01; 19(1):53-8. PubMed ID: 10879242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.